{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:29:51Z","timestamp":1781530191955,"version":"3.54.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.trim.2017.08.001","type":"journal-article","created":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T16:47:50Z","timestamp":1501778870000},"page":"8-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Deleterious impact of C3d-binding donor-specific anti-HLA antibodies after pediatric liver transplantation"],"prefix":"10.1016","volume":"45","author":[{"given":"Eduardo","family":"Couchonnal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Rivet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Ducreux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Dumortier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexie","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Boillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8604-1089","authenticated-orcid":false,"given":"Sophie","family":"Collardeau-Frachon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Hervieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Scoazec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Lachaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Guillaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2017.08.001_bb0005","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/TP.0b013e3182139da1","article-title":"Inferior kidney allograft outcomes in patients with de novo donor-specific antibodies are due to acute rejection episodes","volume":"91","author":"Cooper","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2017.08.001_bb0010","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/j.1432-2277.2011.01312.x","article-title":"Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules","volume":"24","author":"Ntokou","year":"2011","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trim.2017.08.001_bb0015","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1432-2277.2008.00755.x","article-title":"Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation","volume":"21","author":"Li","year":"2008","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trim.2017.08.001_bb0020","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1164\/rccm.201312-2160OC","article-title":"Impact of pretransplant anti-HLA antibodies on outcomes in lung transplant candidates","volume":"189","author":"Kim","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.trim.2017.08.001_bb0025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.healun.2014.09.027","article-title":"Outcomes in highly sensitized pediatric heart transplant patients using current management strategies","volume":"34","author":"Asante-Korang","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trim.2017.08.001_bb0030","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/lt.23534","article-title":"Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts","volume":"18","author":"Miyagawa-Hayashino","year":"2012","journal-title":"Liver Transpl."},{"key":"10.1016\/j.trim.2017.08.001_bb0035","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1600-6143.2010.03414.x","article-title":"The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation","volume":"11","author":"Musat","year":"2011","journal-title":"Am. J. Transplant."},{"issue":"2016","key":"10.1016\/j.trim.2017.08.001_bb0040","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/ajt.13909","article-title":"Comprehensive update of the Banff working group on liver allograft pathology: introduction of antibody-mediated rejection","volume":"16","author":"Demetris","year":"2016","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2017.08.001_bb0045","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/TP.0b013e3182782fef","article-title":"Predicting operational tolerance in pediatric living-donor liver transplantation by absence of HLA antibodies","volume":"95","author":"Waki","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2017.08.001_bb0050","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/tri.12654","article-title":"De novo donor-specific anti-HLA antibodies mediated rejection in liver-transplant patients","volume":"28","author":"Del Bello","year":"2015","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trim.2017.08.001_bb0055","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1097\/TP.0000000000000613","article-title":"Donor-specific anti-HLA antibodies and endothelial C4d deposition-association with chronic liver allograft failure","volume":"99","author":"Iacob","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2017.08.001_bb0060","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/lt.23854","article-title":"Donor-specific alloantibodies are associated with fibrosis progression after liver transplantation in hepatitis C virus-infected patients","volume":"20","author":"O'Leary","year":"2014","journal-title":"Liver Transpl."},{"key":"10.1016\/j.trim.2017.08.001_bb0065","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1097\/TP.0000000000000638","article-title":"Long-term clinical relevance of de novo donor-specific antibodies after pediatric liver transplantation","volume":"99","author":"Grabhorn","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2017.08.001_bb0070","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/tri.12747","article-title":"Donor-specific antibodies after pediatric liver transplantation: a cross-sectional study of 50 patients","volume":"29","author":"Kivel\u00e4","year":"2016","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trim.2017.08.001_bb0075","doi-asserted-by":"crossref","first-page":"119","DOI":"10.12659\/AOT.889921","article-title":"Antibody-mediated rejection in pediatric liver transplant recipients","volume":"19","author":"Markiewicz-Kijewska","year":"2014","journal-title":"Ann. Transplant."},{"key":"10.1016\/j.trim.2017.08.001_bb0080","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1097\/TP.0000000000000796","article-title":"Donor-specific HLA antibodies are associated with late allograft dysfunction after pediatric liver transplantation","volume":"99","author":"Wozniak","year":"2015","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.trim.2017.08.001_bb0085","doi-asserted-by":"crossref","DOI":"10.1111\/petr.12791","article-title":"Acute antibody-mediated rejection in ABO-compatible pediatric liver transplant recipients: case series and review of the literature","volume":"21","author":"Wozniak","year":"2017","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.trim.2017.08.001_bb0090","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trim.2017.08.001_bb0095","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1681\/ASN.2013101144","article-title":"Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss","volume":"26","author":"Sicard","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2017.08.001_bb0100","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/ajt.13153","article-title":"Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation","volume":"15","author":"O'Leary","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2017.08.001_bb0105","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/lt.23451","article-title":"Donor-specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with chronic rejection and graft loss after liver transplantation","volume":"18","author":"Kaneku","year":"2012","journal-title":"Liver Transpl."},{"key":"10.1016\/j.trim.2017.08.001_bb0110","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.510310337","article-title":"Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel","volume":"31","author":"Demetris","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.trim.2017.08.001_bb0115","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.trim.2017.08.001_bb0120","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/ajt.12651","article-title":"Prevalence, incidence and risk factors for donor-specific anti-HLA antibodies in maintenance liver transplant patients","volume":"14","author":"Del Bello","year":"2014","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2017.08.001_bb0125","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1432-2277.2009.01022.x","article-title":"Prevalence of anti-HLA antibodies after liver transplantation","volume":"23","author":"Fontana","year":"2010","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trim.2017.08.001_bb0130","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1499-3872(15)60391-5","article-title":"Clinical factors affecting rejection rates in liver transplantation","volume":"14","author":"Au","year":"2015","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.trim.2017.08.001_bb0135","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.transproceed.2012.07.069","article-title":"Liver transplantation due to fulminant hepatic failure","volume":"44","author":"G\u00f3mez Cabeza de Vaca","year":"2012","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.trim.2017.08.001_bb0140","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/j.1600-6143.2011.03593.x","article-title":"High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection postliver transplant","volume":"11","author":"O'Leary","year":"2011","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2017.08.001_bb0145","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/ajt.12667","article-title":"The role of donor-specific HLA alloantibodies in liver transplantation","volume":"14","author":"O'Leary","year":"2014","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2017.08.001_bb0150","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/TP.0000000000000185","article-title":"Association of anti-human leukocyte antigen and anti-angiotensin II type 1 receptor antibodies with liver allograft fibrosis after immunosuppression withdrawal","volume":"98","author":"Ohe","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2017.08.001_bb0155","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/hep.22686","article-title":"Graft fibrosis after pediatric liver transplantation: ten years of follow-up","volume":"49","author":"Scheenstra","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.trim.2017.08.001_bb0160","doi-asserted-by":"crossref","DOI":"10.1111\/petr.12988","article-title":"Unique clinical conditions associated with different acinar regions of fibrosis in long-term surviving pediatric liver grafts","author":"Baas","year":"2017","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.trim.2017.08.001_bb0165","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/j.1432-2277.2005.00200.x","article-title":"A case of acute humoral rejection in liver transplantation: successful treatment with plasmapheresis and mycophenolate mofetil","volume":"18","author":"Rostron","year":"2005","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trim.2017.08.001_bb0170","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.3748\/wjg.15.3426","article-title":"Early plasmapheresis and rituximab for acute humoral rejection after ABO-compatible liver transplantation","volume":"15","author":"Kamar","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.trim.2017.08.001_bb0175","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.transproceed.2008.02.061","article-title":"Antibody-mediated rejection: hyperacute rejection reality in liver transplantation? A case report","volume":"40","author":"Della-Guardia","year":"2008","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.trim.2017.08.001_bb0180","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/lt.23788","article-title":"Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss","volume":"20","author":"O'Leary","year":"2014","journal-title":"Liver Transpl."},{"key":"10.1016\/j.trim.2017.08.001_bb0185","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/lt.23687","article-title":"Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation","volume":"19","author":"O'Leary","year":"2013","journal-title":"Liver Transpl."},{"key":"10.1016\/j.trim.2017.08.001_bb0190","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/ajt.12212","article-title":"De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients","volume":"13","author":"Kaneku","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2017.08.001_bb0195","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.trim.2009.06.004","article-title":"Vascular deposition of complement C4d is increased in liver allografts with chronic rejection","volume":"21","author":"Martelius","year":"2009","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.trim.2017.08.001_bb0200","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.trim.2011.08.005","article-title":"Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection","volume":"26","author":"Ali","year":"2012","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.trim.2017.08.001_bb0205","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.trim.2016.01.007","article-title":"Monitoring efficiency of humoral rejection episode therapy in liver transplantation: any role for complement binding Luminex Single Antigen assays?","volume":"35","author":"Ducreux","year":"2016","journal-title":"Transpl. Immunol."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096632741630154X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096632741630154X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T15:50:06Z","timestamp":1535557806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096632741630154X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":41,"alternative-id":["S096632741630154X"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2017.08.001","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deleterious impact of C3d-binding donor-specific anti-HLA antibodies after pediatric liver transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2017.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}